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Summary: Six commercially available radioimmunoassay (RIA) kits for human follitropin (follicle-stimulat-
ing hormone; hFSH) were compared with respect to precision, "accuracy", specificity and performance. The
intra- and interassay coefficients of Variation ranged from 4.7 to 8.3% and from 6.5 to 13.3%, respectively.
The recovery of added follitropin ranged from 88 to 176%. The most important conclusion of this study is that
an accurate calibration of the kit Standard by the manufacturer is essential for minimizing the Variation be-
tween kits.
«
Vergleich von sechs Radioimmunoassay-Bestecks zur Bestimmung von menschlichem Follitropin im Serum
Zusammenfassung: Sechs kommerziell erhältliche Radioimmunassay-Bestecks zur Bestimmung menschli-
chen Follitropin wurden hinsichtlich Präzision, Richtigkeit, Spezifität und Durchführung verglichen. Die Va-
riationskoeffizienten betrugen in der Serie 4,7 bis 8,3%, von Tag zu Tag 6,5 bis 13,3%. Die Wiederfindung
zugesetzten Foljitropins reichte von 88 bis 176%. Die wichtigste Schlußfolgerung aus dieser Untersuchung ist,
daß eine richtige Kalibrierung des Standards im Testbesteck durch den Hersteller für die Verminderung der
Variation der mit den Bestecks erzielten Ergebnisse von ausschlaggebender Bedeutung ist.
Introduction
Standardization, quality control, reference sera have
become common concepts in clinical laboratories.
Besides using intemal qüälity control schemes most
laboratöries participate in one or more external
quality contröl programmes. At regulär intervals the
participants receive samples for analysis. The re-
turned results are evaluated and each participant is
informed about his result in comparison with all pth-
er participants or with the users of "the same rea-
gents. The reports of such external quality control··
progräinmes show that the use of different methods
and reagents adds greatly to the between-laborato-
ry Variation. The present study, on six kits for the
determination of the pituitary hormone follitropin,
was undertaken to determine how these kits differ
and how they may be improved.
0 Reference to a Company and/or product is only for the purpose
of Information and identification and does not imply approval
or recommendation of the Company and/or product by the Na-
tional Institute of Public Health to the exclusion of others.
Materials and Methods
In this study, carried out in the first trimester of 1982, the follow-
ing kits1) were used and further referred to äs mentioned in par-
entheses:
1. RIA-gnost® hFSH; Behringwerke AG, D-3550 Marburg,
Germany (Behring); batch Nos. W1007, W1010 and A1002.
2. Biodata FSH-DAB; Hypolab S.A., CH-1267 Coinsins, Swit-
zerland (Biodata); batch Nos. 103211 and 103213.
3. RIA-mat® FSH; Byk-Mallinckrodt, D-6057 Dietzenbach-
Steinberg, Germany (Byk); batch Nos. 2021, 2041 and 2081.
4. DPC FSH-RIA; Diagnostic Products Corporation, Los An-
geles, California, U.S.A. (DPC); batch Nos. 052, 056 and 059.
5. IRE-FSH-RIA; IRE, B-6220 Fleurus, Belgium (IRE); batch
Nos. 181181, 1811281 and 180182.
6. FSH-RIA IM72; The Radiochemical Centre, Amersham,
U.K. (RCA); batch Nos. 183, 187 and 190A.
The following International Reference Preparations (IRP) were
kindly donated by the National Institute for Biological Standards
and Control (London, U.K.) and are further referred to äs men-
tioned in parentheses: the Ist and 2nd IRP for human follitropin
(FSH)/lutropin (LH) for bioassay (69/104 and 78/549, respec-
tively), the Ist IRP for human thyrotropin (TSH) for immunoas-
say (68/38), the Ist IRP for human lutropin (LH) for imrnunoas-
say (68/40), and the Ist IRP for human chorionic gonadotropin
(CG) for immunoassay (75/537).
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Bovine serum albumin (BSA; Poviet) was purchased from Organ-
on, Oss. Serum and plasma samples with various follitropin con-
centrations, were kindly donated by Prof. dr. J. H. H. Thijssen and
Dr. C. J. P. Aisbach, Academic Hospital, Utrecht and Dr. W.
Schopman, Bergweg Hospital, Rotterdam.
All experiments were carried out by the same technician. The
RIA results were calculated using a Computer program developed
by Rodbard (1).
Results and Discussion
Technical Data
Table l shows certain technical data for each kit,
such äs the reference preparation used for calibra-
tion of the kit Standard, conditions for (pre-)incuba-
tion and the Separation method.
The World Health Organization (WHÜ) has recent-
ly established International Reference Preparations
for the immunoässay (2) of a number of hormones,
but not follitropin. In the meantime, WHO recom-
mends that 6971 Oft, which has been established for
bioassay, should also be used for the follitropin im-
munoässay. Recently, this preparation has been re-
placed by 78/549 which is equipotent (3). Two kits,.
DPC and RCA, still use the obsolete urinary refer-
ence preparation 2nd IRP of Human Menopausal
Gonadotropin (hMG), but provide a conversion fac-
tor for calculation in terms of 69/104 and 78/549. In
one experiment with each kit a dilution series of 69/
104 was compared with one of 78/549. In all cases
the two curves were coincident. Hence, for brevity,
all further results are expressed in terms of 78/549.
The amount of radioactivity per 100 tubes for the
kits investigated here varies from 44 kBq (Biodata)
to 148 kBq (Byk). This last figure appeared to corre-
spond to 40000—50000 counts per minute per tube.
It is obvioüs that both the manufacturer and the user
are interested in counting times that are äs short äs
possible, but with suffieient counting precision.
However, from the point of view of environmental
protection äs well äs radiation exposure of the tech-
nician it is important to keep the amoürit of radioac-
tivity äs low äs possible. To us, these two arguments
are more important than the relatively small increase
in counting time.
Precision
For the determination of the intra- and interassay
Variation, eight sera, coded A to H, were analysed in
triplicate with each kit. In each experiment a dilution
series of 78/549 was assayed äs well. This prepara-
tion was dissolved and dihited in phosphate-buffered
saline pH 7.4 containing 10 g/l bovine serum album-
in for analysis by Biodata, IRE and RCA, and in the
corresponding matrix of the kit Standard for analysis
by Behring, Byk and DPC.
For radioimmunoassays the intra- and interassay
coefficients of Variation are dependent on the ana-
lyte concentration. Therefore^ for each serum sam-
ple the results of the six experiments per kit were
submitted to an analysis of variance according to
McDonagh et al. (4), thus yielding an estimate both
for the cumülative intra-assay Variation and the cu-
Tab. 1. Technical data
Standard Radio-
activity
IRP matrix (kBq)2)
Pipetting Separation
steps method
Incubation time (h) Separation B/F (min)
without tracer with tracer incübation centrifuge
Behring
Biodata
Byk
DPC
IRE
RCA
-
69/104
69/104
69/104
2ndIRPHMG
69/104
2ndIRPHMG
HS1)
B
HS
PS
B
B
74
44
148
74
74
92
53)
5
4
4
63)
5
immuno- —
sorbent
DA
-
DA + PEG -
16-24
DA + PEG 2/37 °C
2/37 °C
immuno- —
sorbent
DA +
(NH4)2S04
16-24
3
16-244)
16-244)
16-24
2/37 °C
154)
18-24
16-24
15
60
120
30
5
60
5
2 x
30
30
20
2 x
30
<·
20
10
J Abbreviations: HS: human serum; B: buffer; PS: protein-containing solütion; PEG: polyethyleneglycol; DA: double antibody
2) number of kBq per 100 tubes (l kBq = 0.027 uCi)
3) including washing of the precipitate
4) incübation times chosen in the study
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mulative interassay Variation. These estimates are
shown in tables 2 and 3, respectively and reflect the
so called „precision profile" (5). To facilitate the
overview, the median of the estimates per kit is also
given. Behring shows the highest intraassay Variation
and DPC the highest interassay Variation, but the
differences with the other kits are relatively small.
Accuracy
The above experiments provided the mean follitrop-
in concentration of each sample for each assay kit,
and an overall mean for each sample based on analy-
sis by all six kits. Table 4 shows the results. To deter-
mine whether any kit systematically yields high or
low follitropin vaiues the kits have been ranked from
l to 6 aceording to their results for each serum sam-
ple. The kit yielding the lowest follitropin value for
serum A was given number l, the kit yielding the
next higher value was given number 2, etc. The same
procedure was followed for the other sera and the
results per kit were summed.
According to Thompson & Willke (6) for 8 sera and
6 kits the 5% significance vaiues for the sum of the
ranking numbers are 15 and 41. The ranking
numbers and the sums are presented in table 5. It
appears that Byk measures systematically lower and
Behring higher than the other kits. Since in all exper-
iments a dilution series of 78/549 was assayed it was
possible to read the serum samples on this curve
(tab. 6) and to recalculate the ranking (tab. 7). It is
striking that Behring then shows a "normal" level
whereas Byk still measures relatively low and IRE
Tab. 2. Intra assay Variation for the samples A to H calculated from the results in triplicate of 6 assays.
Coefficient of Variation (%)
D E * F G H
Tab. 3. Inter assay Variation for the samples A to H calculated from the results in triplicate of 6 assays.
B
Coefficient of Variation (%)
D E F G H
Median
Behring
Biodata
Byk
DPC
IRE
RCA
16.2
10.7
6,8
18.9
8.2
6.0
13.7
6.0
10.8
13.8
5.1
7.8
9.9
4.5
3.1
7.4
6.2
6.4
9.9
6.9
3.3
7.5
5.8
5.8
6.7
5.6
3.7
5.1
5.9
3.8
3.3
10.9
5.6
6.2
6.4
5.6
6.3
3.2
2.1
3.6
4.7
4.5
4.7
6.0
8.0
5.2
4.8
4.1
8.3
5.8
4.7
6.8
5.9
5.6
Median
Behring
Biodata
Byk
DPC
IRE
RCA
16.2
32.8
17.3
25.1
14.7
6.9
26.7
9.4
12,8
27.1
9.0
27.0
12.6
6.2
5.0
13.0
9.7
9.5
10.4
10.1
6.4
15.6
10.4
6.5
11.2
6.4
4.1
13.5
9.7
5.5
6.5
12.0
6.7
10.4
9.3
6.4
12.2
7.4
5.7
5.7
8.0
4.9
6.2
6.2
8.0
7.0
7.9
5.1
11.8
8.4
6.6
13.3
9.5
6.5
Tab. 4. Mean follitropin concentration of the samples A to H with respect to the kit Standard calculated from 6 assays.
Follitropin concentration (IU/1)
D E H
Behring
Biodata
Byk
DPC
IRE
RCA
X
CV(%)
3.6
1.2
1.2
1.9
2.4
2,7
2.2
43
4.6
2.2
1.2
3.1
4.4
2.2
3.0
46
7.0
3.7
3.5
4.4
6.7
3.7
4.8·.
33
11.1
6.1
6.0
6.6
10.9
5.9
7.8
32
16.4
8.8
9.1
8.8
15.2
8.4
11.1
33
37.7
19.5
17.9
18.8
35.0
18.2
24.5
38
43.2
27.0
23.9
28.9
53.2
23.3
33.2
37
68.3
37.1
34.1
38.2
73.9
36.2
48.0
38
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Tab. 5. Ranking numbers for the samples A to H calculated with respect to the kit Standard
A B C D E F G H Sum1)
Behring
Biodata
Byk
DPC
IRE
RCA
6
1.5
1.5
3
4
5
6
2.5
1
4
5
2.5
6
2.5
1
4
5
2.5
6
3
2
4
5
1
6
2.5
4
2.5
5
1
6
4
1
3
5
2
5
3
2
4
6
1
5
3
1
4 ·
6
2
46
22
13.5
28.5
41
17
!) For 6 kits and 8 samples the 5% significance values are 15 and 41 (ref. (6))
Tab. 6. Mean follitropin concentration for the samples A to H with respect to follitropin 78/549.
B
Follitropin concentration (IU/1)
P E
Tab. 7. Ranking numbers for the samples A to H calculated with respect to follitropin 78/549.
B D
For 6 kits and 8 samples the 5% significance values are 15 and 41 (ref. (6))
H
H
Behring
Biodata
Byk
DPC
IRE
RCA
X
CV (%)
2.2
1.4
0.8
1.7
2.1
2,4
1.8
34
2.8
2.9
0.8
2.8
3.7
1.9
2.5
40
4.4
4.8
2.7
4.1
5.7
3.4
4.2
25
6.9
7.8
5.2
6.2
9.1
5.5
6.8
22
10.2
11.0
8.1
8.6
12.7
.8.1
9.8
19
23,9
23.4
17.0
18.9
29.3
18.6
21.8
21
27.4
32.1
23.9
29.4
44.7
24.1
30.3
26
43.7
44,0
36.8
39.2
62.4
38.8
44.2
21
Sum1)
Behring
Biodata
Byk
DPC
IRE
RCA
5
2
1
3
4
6
3.5
5
1
3.5
6
2
4
5
1
3
6
2
4
5
1
3
6
2
4
5
1.5
3
6
1.5
5
4
1
3
6
2
3
5
1
4
6
2
4
5
1
3
6
' t
32.5
36
8.5
25.5
46
19.5
relatively high. For follitropin there is no definitive
method so it cannot be stated that the results of any
particular kit are wrong. In addition, the ranking de-
pends on the choice of kits being investigated. None-
theless, it was decided to further investigate the cali-
bration of the kit Standards.
Calibrat ion of kit Standards and recovery
experiments
By direct cömparison of the calibration curves of the
kit Standard and 78/549 a potency was calculated for
each kit. The ratio of this potency and the one stated
by the manufacturer is shown in table 8. In addition,
a recovery experiment was carried out äs follows. To
a plasma sample with a low follitropin concentration,
78/549 was added in amounts of 2.5, 5, 10, 20 and
40IU per Ihre. For each kit the spiked samples were
assayed in one experiment in quadruplicate. The fol·
litropin concentration was calculated with respect to
the kit Standard and to 78/549. The percentage re-
covery is shown in table 9. From table 8 it is elear
that the potency of the kit Standards with respect to
78/549 differ from the expected value of 1.0, mainly
for Behring and Biodata and to a smaller degree for
Byk and IRE. The kit Standard of Biodata has been
underestimated whereas the others have been over-
estimated. These disprepancies are not caused by
matrix effects, since for each kit 78/549 was dis-
solved in the matrix prescribed fpr the kit Standard.
For Behring, Biodata and IRE these findings do
agr^e with the results of the recovery experiment
(tab. 9); the recovery with respect to 78/549 was
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Tab. 8. The ratio of the immunochemical potency of the kit
Standard with respect to 78/549 äs observed in this study
and äs stated by the manufacturer.
Behring
Biodata
Byk
DPC
IRE
RCA
0.68
1.27
0.86
0.96
0.85
0.97
(0.64-0.73)1)
(1.24-1.31)
(0.82-0.91)
(0.92-1.00)
(0.83-0.86)
(0.94-0.99)
n = 22
n = 4
n = 2
n = 3
n = 6
n = 6
!) 95% confidence limits
2) number of assays
Tab. 9. Percentage recovery of follitropin (FSH) 78/549 added
to plasma, calculated with respect to the kit Standard and
to follitropin (FSH) 78/549. Additions were 2.5, 5, 10,
20 and 40 IU follitropin (FSH) 78/549 per liter plasma.
Recovery (%, ± s, n = 20)
Kit Standard FSH 78/549
Behring
Biodata
Byk
DPC
IRE
RCA
176 ± 22
88 ± 10
105 ± 14
109 ± 8
132 ± 7
101± 9
114± 15
96 ± 11
106 ± 8
106 ± 8
109 ± 6
108 ± 8
normal whereas the recovery with respect to the kit
Standard was too high for Behring and IRE and too
low for Biodata.
It is obvious that incörtect calibration of the kit
Standard adds to the Variation between kits. This is
clearly seen when tables 4 and 6 are compared. The
median coefficient of Variation of the overall mean
follitropin concentration per sample descreases fröm
38%, when the follitropin concentration is calculat-
ed using the kit Standard, to 23% when the follitrop-
in concentration is calculated using 78/549. It fol-
lows that a more precise calibration of the kit Stand-
ard will meän a great improvement in the process of
standardization and qüality coijtrol.
Specifity
Simiiarities in the structures of follitropin, thyrotrop-
in, lutropin and chorionic gonadotropin sometimes
lead to cross reactions in assay Systems. The specifi-
ty of the kits was tested with the preparations TSH
68/38, LH 68/40 and hCG 75/537 in amounts up to
100 mlU, 400 IU and 400 IU per Ihre serum, re-
spectively. Gare was taken to dissolve these in the
same matrix äs the respective kit Standard.
Usually, specificity is expressed äs the percentage
cross reaction, i. e. the mass of the analyte causing
50% decrease of initial binding divided by the mass
of the cross reacting compound causing a similar de-
crease. In the present study, such a calculation is im-
possible for two reasons. Firstly, for 5 of the 6 kits to
reach a 50% decrease of the initial binding a tre-
mendous amount of LH 68/40 and hCG 75/537
would have to be used; secondly, it is meaningless to
calculate a ratio of e.g. International Units of folli-
tropin and International Units of lutropin. Hence,
the specifity is expressed äs the concentration of thy-
rotropin, lutropin or chorionic gonadotropin that
causes a decrease of the binding to 90% of the initial
value (tab. 10). In general, the TSH 68/38 curves
ran parallel to 78/549. Moreover, the relative poten-
cy was appröximately the same for all kits. It is con-
cluded, therefore, that the thyrotropin „cross reac-
tion" in fact is caused by follitropin contamination in
TSH 68/38. The lutropin cross reaction is too low to
cause interference with the measurement of folli-
tropin in physiological samples, except for RCA.
The cross reaction of human chorionic gonadotropin
(hCG) 75/537 in the case of Behring, Byk and in
particular RCA is rather high. To show this, two sera
of pregnant women (hCG>10000 IU/1) were as-
sayed. It cari be seen from table 11 that these 3 kits
give relatively high values. Concerning specifity it
must be stated that only Biodata and RCA provide
figures. Behring does not mention specifity at all
Tab. 10. Specificity of the antisera expressed äs the concentration of human follitropin (hFSH), human thyrotropin (hTSH), human
lutropin (hLH) and human chorionic gonadotropin (hCG), respectively, causing a decrease of the binding to 90% of the initial
binding.
Behring
Biodata
Byk
DPC
IRE
RCA
hFSH 78/549
IÜ/1 serum
1.3
1.1
0.4
1.3
0.9
0.6
hTSH 68/38
IU/1 serum
29
28
36
38
20
10
hLH 68/40
IU/1 serum
160
>400
240
>400
360
12
hCG 75/537
IU/1 serum
400
>400
240
>400
>400
14
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Tab. 11. Follitropin concentration (IU/1) in two sera from preg-
nant women (hCG > 10000 IU/1 sefum).
Behring
Biodata
Byk
DPC
IRE
RCA
Serum
I
3.5«)
1.4
3.0
1.4
1.9
4.0
t Serum
II
5.2
1.7 ·
3.8
1.4
1.9
5.1
>) mean of at least 2 assays in triplicate
and, like Byk, does not warn against cross reaction
with chorionic gonätropin. IRE and DPC do provide
cross reaction figures for lutropin, thyrotropin and
chorionic gonadotropin but this Information is
worthless since the purity of the preparations used is
not stated. We realise that our chöice, öf the thyro-
tropin, lutrqpm and chorionic gonadotropin prepa-
rations for the study of the specificity can be debated
with fespect to their purity. On the other händ these
international refereiice preparations have been very
well documented and are freely availäble.
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